Literature DB >> 5794251

Human prothrombin metabolism in normal man and in hypocoagulable subjects.

S S Shapiro, J Martinez.   

Abstract

The metabolism of human prothrombin labeled with radioactive iodine was studied in seven normal subjects and four hemophilic patients. Results in the normal subjects were: plasma volume, 37.6+/-3.8 ml/kg; plasma prothrombin concentration, 303+/-40 U/ml (0.153+/-0.02 mg/ml); prothrombin half-life, 2.81+/-0.51 days; total plasma prothrombin pool, 5.72+/-0.62 mg/kg, representing 64.1+/-9.1% of total body prothrombin; fractional catabolic rate, 42.5+/-12.4% of the plasma pool per day; prothrombin synthesis rate, 2.43+/-0.76 mg/kg per day. Results in the hemophilic patients did not differ significantly from normal. Circulating products of prothrombin activation could not be demonstrated in normal individuals or hemophilic subjects. The data suggest that continuous physiologic activation of the blood coagulation mechanism plays only a small part, if any, in the normal catabolism of prothrombin.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5794251      PMCID: PMC322352          DOI: 10.1172/JCI106095

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.

Authors:  R BIGGS; K W DENSON
Journal:  Br J Haematol       Date:  1963-10       Impact factor: 6.998

2.  THE BIOLOGICAL DISAPPEARANCE RATE OF PROTHROMBIN, FACTORS VII, IX AND X FROM PLASMA IN HYPOTHYROIDISM, HYPERTHYROIDISM, AND DURING FEVER.

Authors:  E A LOELIGER; B VAN DER ESCH; M J MATTERN; H C HEMKER
Journal:  Thromb Diath Haemorrh       Date:  1964-01-01

3.  Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men.

Authors:  Y TAKEDA; E B REEVE
Journal:  J Lab Clin Med       Date:  1963-02

4.  A study of a case of congenital hypoprothrombinaemia.

Authors:  C F BORCHGREVINK; O EGEBERG; J G POOL; T SKULASON; H STORMORKEN; B WAALER
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

5.  Starch gel electrophoresis in a discontinous system of buffers.

Authors:  M D POULIK
Journal:  Nature       Date:  1957-12-28       Impact factor: 49.962

6.  Amino acid composition of human plasma prothrombin.

Authors:  G F Lanchantin; D W Hart; J A Friedmann; N V Saavedra; J W Mehl
Journal:  J Biol Chem       Date:  1968-10-25       Impact factor: 5.157

7.  Clinical use of human prothrombin complexes.

Authors:  J L Tullis; M Melin; P Jurigian
Journal:  N Engl J Med       Date:  1965-09-23       Impact factor: 91.245

8.  Alpha-2-macroglobulin as progressive antithrombin.

Authors:  M Steinbuch; C Blatrix; F Josso
Journal:  Nature       Date:  1967-11-04       Impact factor: 49.962

9.  In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors:  L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Human prothrombin activation.

Authors:  S S Shapiro
Journal:  Science       Date:  1968-10-04       Impact factor: 47.728

View more
  12 in total

1.  Response to R-warfarin anticoagulant effect.

Authors:  Ling Xue; Nick Holford; Li-Yan Miao
Journal:  Br J Clin Pharmacol       Date:  2017-07-23       Impact factor: 4.335

2.  R-warfarin anticoagulant effect.

Authors:  Roberto Padrini; Luigi Quintieri
Journal:  Br J Clin Pharmacol       Date:  2017-05-11       Impact factor: 4.335

3.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

Authors:  K A Bauer; L M Weiss; D Sparrow; P S Vokonas; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.

Authors:  Heather K Kroh; Peter Panizzi; Svetlana Tchaikovski; T Regan Baird; Nancy Wei; Sriram Krishnaswamy; Guido Tans; Jan Rosing; Bruce Furie; Barbara C Furie; Paul E Bock
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

5.  Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.

Authors:  J Martinez; R R Holburn; S S Shapiro; A J Erslev
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

6.  Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

Authors:  K A Bauer; T L Goodman; B L Kass; R D Rosenberg
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet.

Authors:  K A Mitropoulos; M P Esnouf
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

8.  Characterization of human plasma proteome dynamics using deuterium oxide.

Authors:  Ding Wang; David A Liem; Edward Lau; Dominic C M Ng; Brian J Bleakley; Martin Cadeiras; Mario C Deng; Maggie P Y Lam; Peipei Ping
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

9.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.

Authors:  S S Shapiro; J Martinez; R R Holburn
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.